USPTO serial 79287488
BIO-COURIER
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- CARR, PATRICK C
- Law office
- TMO LAW OFFICE 125 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with BIO-COURIER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals and chemical preparations for use in industry, science and research; biochemical substances and biochemical preparations for use in industry, science and research; biological substances and biological preparations for use in industry, science and research; nanoparticle substances and nanoparticles for use in industry, science and research; silicon for use in industry, science and research; silicon nanoparticle materials for use in industry, science and research; porous silicon nanoparticle materials for use in industry, science and research; chemical materials for carrying and delivery of chemical, biochemical and biological substances; nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances; chemical materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of cosmetics; nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of cosmetics; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of cosmetics; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of cosmetics; chemical materials for carrying and delivery of chemical, biochemical and biological substances for skin care preparations; nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for skin care preparations; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for skin care preparations; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for skin care preparations; chemical materials for stabilising of chemical, biochemical and biological substances; nanoparticle materials for stabilising of chemical, biochemical and biological substances; silicon nanoparticle materials for stabilising of chemical, biochemical and biological substances; porous silicon nanoparticle materials for stabilising of chemical, biochemical and biological substances | ACTIVE | — |
| 005 | Chemicals and chemical preparations for medical, veterinary and pharmaceutical purposes; chemicals and chemical preparations for medical, veterinary and pharmaceutical research purposes; chemicals and chemical preparations for medical, veterinary and pharmaceutical treatment purposes; biochemical substances and biochemical preparations for medical, veterinary and pharmaceutical purposes; biochemical substances and biochemical preparations for medical, veterinary and pharmaceutical research purposes; biochemical substances and biochemical preparations for medical, veterinary and pharmaceutical treatment purposes; biological substances and biological preparations for medical, veterinary and pharmaceutical purposes; biological substances and biological preparations for medical, veterinary and pharmaceutical research purposes; biological substances and biological preparations for medical, veterinary and pharmaceutical treatment purposes; nanoparticle substances and nanoparticle preparations for medical, veterinary and pharmaceutical purposes; nanoparticle substances and nanoparticle preparations for medical, veterinary and pharmaceutical research purposes; nanoparticle substances and nanoparticle preparations for medical, veterinary and pharmaceutical treatment purposes; preparations of trace elements for human and animal use; silicon for medical, veterinary and pharmaceutical purposes; silicon nanoparticle materials for medical, veterinary and pharmaceutical purposes; porous silicon nanoparticle materials for medical, veterinary and pharmaceutical purposes; pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical porous silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for vaccines; pharmaceutical nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for vaccines; pharmaceutical silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for vaccines; pharmaceutical porous silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for vaccines; pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for antiseptics; pharmaceutical nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for antiseptics; pharmaceutical silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for antiseptics; pharmaceutical porous silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for antiseptics; pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for antibiotics; pharmaceutical nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for antibiotics; pharmaceutical silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for antibiotics; pharmaceutical porous silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for antibiotics; pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for dermatological treatment preparations; pharmaceutical nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for dermatological treatment preparations; pharmaceutical silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for dermatological treatment preparations; pharmaceutical porous silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for dermatological treatment preparations; pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for skin care preparations; pharmaceutical nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for skin care preparations; pharmaceutical silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for skin care preparations; pharmaceutical porous silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for skin care preparations; pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for drug delivery devices; pharmaceutical nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for drug delivery devices; pharmaceutical silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for drug delivery devices; pharmaceutical porous silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances for drug delivery devices; pharmaceutical preparations for stabilising of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical nanoparticle preparations for stabilising of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical silicon nanoparticle preparations for stabilising of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical porous silicon nanoparticle preparations for stabilising of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical preparations for controlled release and onset of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical nanoparticle preparations for controlled release and onset of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical silicon nanoparticle preparations for controlled release and onset of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical porous silicon nanoparticle preparations for controlled release and onset of chemical, biochemical, biological and pharmaceutical substances | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 27, 2022 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 7, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 5, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 5, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 17, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 17, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 5, 2021 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 5, 2021 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 14, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 25, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 25, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 21, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 20, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 19, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 15, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 15, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 11, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |